Journal
DERMATOLOGY AND THERAPY
Volume 10, Issue 5, Pages 1181-1184Publisher
ADIS INT LTD
DOI: 10.1007/s13555-020-00421-8
Keywords
Hypomyopathic dermatomyositis; Refractory dermatitis; Low-dose IL-2
Categories
Ask authors/readers for more resources
Hypomyopathic dermatomyositis (DM) presents with cutaneous lesions consistent with dermatomyositis but in the absence of clinically appreciable muscle weakness. The cutaneous manifestations are often refractory and more resistant to conventional therapy than concomitant muscle involvement. We present a 61-year-old hypomyopathic patient with DM who failed to respond to standard therapy but was successfully treated by low-dose interleukin-2 (IL-2) with no significant side effects. We conclude that low-dose IL-2 is a safe and effective treatment for hypomyopathic DM.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available